IPSEN BIOPHARM LIMITED
Company Information
- Company Number
- 01653765
- Registered Address
- Ash Road, Wrexham Industrial Estate, Wrexham, LL13 9UF
- Status
- Active
- Employee Count
- 633
- Turnover
- £553,520,000
- EBITDA
- £216,742,000
Additional Details
- Website
- https://ipsen.com
- Company Type
- Private limited Company
- Incorporated On
- 23 July 1982
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Coming Soon
- Region
- Wales
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 34 | 56% | 35% | 9% | 23% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 32 | 67% | 23% | 10% | 22% |
| 01 Jan 2023 - 30 Jun 2023 | 31 Jul 2023 | 30 | 66% | 28% | 6% | 29% |
| 01 Jul 2022 - 31 Dec 2022 | 25 Jan 2023 | 30 | 64% | 31% | 5% | 28% |
| 01 Jan 2022 - 30 Jun 2022 | 21 Jul 2022 | 32 | 63% | 29% | 8% | 22% |
| 01 Jul 2021 - 31 Dec 2021 | 25 Jan 2022 | 29 | 67% | 29% | 4% | 19% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 28 | 73% | 23% | 4% | 23% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 30 | 75% | 21% | 4% | 19% |
| 01 Jan 2019 - 30 Jun 2019 | 26 Jul 2019 | 30 | 73% | 22% | 5% | 22% |
| 01 Jul 2018 - 31 Dec 2018 | 25 Jan 2019 | 30 | 67% | 29% | 4% | 20% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms: 30 days from the invoices date for third party vendors 45days end of the month for intercompany transactions
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Dispute Resolution Process
In case of any discrepancy between goods received and invoice receipt - person who made an order is responsible for contacting the vendor and understand the difference There is a generic email address and direct phone number available for all vendors where all payment related questions can be routed Terms and conditions are attached to the copy of the Purchase Order that is sent to vendors
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
IPSEN BIOPHARM LIMITED is a leading biopharmaceutical company that focuses on developing and providing innovative treatments for patients living with serious diseases. The company is committed to sustainability, both in its operations and in the development of its products.
The company's sustainability program is guided by its core values of integrity, respect, and responsibility. IPSEN BIOPHARM LIMITED aims to reduce its environmental impact by implementing sustainable practices in its facilities and supply chain. This includes reducing energy consumption, minimizing waste, and promoting responsible sourcing of materials.
IPSEN BIOPHARM LIMITED offers a wide range of products and services in the areas of oncology, neuroscience, and rare diseases. Their portfolio includes both innovative medicines and generic drugs, providing patients with access to cost-effective treatments. The company is constantly investing in research and development to bring new and improved therapies to market.
The key people behind IPSEN BIOPHARM LIMITED's success include its CEO David Meek and its Executive Vice President and Chief Financial Officer Aymeric Le Chatelier. They are supported by a team of experienced professionals dedicated to driving the company's growth and success.
For more information on IPSEN BIOPHARM LIMITED and its products and services, you can visit their website at www.ipsen.com. Their registered office address is at 190 Bath Road, Slough, Berkshire, SL1 3XE, United Kingdom. The company is committed to making a positive impact on the lives of patients and the environment, and their efforts in sustainability and innovation make them a leader in the biopharmaceutical industry.
